CD274 and central nervous system cancer: Since Delta-24-RGDOX injection induced upregulation of PD-L1 expression on the glioma cells, Jiang et al. (2017) combined this virus with an anti-PD-L1 antibody to overcome immunosuppression mediated by PD-L1 expression, resulting in a long-term survival rate of 85%.